These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104. Vesicle-independent extracellular release of a proinflammatory outer membrane lipoprotein in free-soluble form. Karched M; Ihalin R; Eneslätt K; Zhong D; Oscarsson J; Wai SN; Chen C; Asikainen SE BMC Microbiol; 2008 Jan; 8():18. PubMed ID: 18226201 [TBL] [Abstract][Full Text] [Related]
105. Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis. Valentine CH; Hellman J; Beasley-Topliffe LK; Bagchi A; Warren HS Mol Med; 2006; 12(9-10):252-8. PubMed ID: 17225874 [TBL] [Abstract][Full Text] [Related]
106. A model of infected burn wounds using Escherichia coli O18:K1:H7 for the study of gram-negative bacteremia and sepsis. Busch NA; Zanzot EM; Loiselle PM; Carter EA; Allaire JE; Yarmush ML; Warren HS Infect Immun; 2000 Jun; 68(6):3349-51. PubMed ID: 10816484 [TBL] [Abstract][Full Text] [Related]
107. Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum. Hellman J; Loiselle PM; Tehan MM; Allaire JE; Boyle LA; Kurnick JT; Andrews DM; Sik Kim K; Warren HS Infect Immun; 2000 May; 68(5):2566-72. PubMed ID: 10768945 [TBL] [Abstract][Full Text] [Related]
108. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5. Baumgartner JD; O'Brien TX; Kirkland TN; Glauser MP; Ziegler EJ J Infect Dis; 1987 Jul; 156(1):136-43. PubMed ID: 2439613 [TBL] [Abstract][Full Text] [Related]
109. Release of gram-negative outer-membrane proteins into human serum and septic rat blood and their interactions with immunoglobulin in antiserum to Escherichia coli J5. Hellman J; Loiselle PM; Zanzot EM; Allaire JE; Tehan MM; Boyle LA; Kurnick JT; Warren HS J Infect Dis; 2000 Mar; 181(3):1034-43. PubMed ID: 10720528 [TBL] [Abstract][Full Text] [Related]
110. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia. Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067 [TBL] [Abstract][Full Text] [Related]
111. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria. Trautmann M; Hahn H Infection; 1985; 13(3):140-5. PubMed ID: 3897069 [TBL] [Abstract][Full Text] [Related]
112. Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria. Hellman J; Zanzot EM; Loiselle PM; Amato SF; Black KM; Ge Y; Kurnick JT; Warren HS J Infect Dis; 1997 Nov; 176(5):1260-8. PubMed ID: 9359727 [TBL] [Abstract][Full Text] [Related]
113. Antiserum treatment of gram-negative bacteremia. Braude AI; Ziegler EJ; McCutchan JA Schweiz Med Wochenschr; 1978 Dec; 108(48):1872-6. PubMed ID: 362528 [TBL] [Abstract][Full Text] [Related]
114. Reactivity of antibodies to core glycolipid with gram-negative bacteria. Shenep JL; Gigliotti F; Davis DS; Hildner WK Rev Infect Dis; 1987; 9 Suppl 5():S639-43. PubMed ID: 2446371 [TBL] [Abstract][Full Text] [Related]